You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of a Diagnostic Test for Eosinophilic Chronic Rhinosinusitis

    SBC: GLYCOMIRA, LLC            Topic: NIAID

    PROJECT SUMMARYThe goal of this proposal is to optimize and clinically validate a new diagnostic test for eosinophilic chronic rhinosinusitis (eCRS) at the point-of-care, improving the efficiency, value, and accessibility of personalized medicine. eCRS affects up to 5 million Americans and is characterized by varying degrees of sinonasal and peripheral eosinophilia, linked to treatment responsiven ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Closed-loop laryngeal pacing for voice restoration

    SBC: RIPPLE LLC            Topic: NIDCD

    Project Summary and Abstract The most common neurogenic voice disorder is unilateral vocal fold paralysis (UVFP), which can substantially reduce quality of life. Current available surgical treatments offer only temporary improvement in voice through placement of resorbable materials or involve permanent, invasive alteration of the larynx that incompletely restores voice and often requires revision ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Identification of Mixed NOP/mu partial agonists as lead compounds for treatment ofmethamphetamine use disorder

    SBC: PHOENIX PHARMALABS, INC.            Topic: NIDA

    Abstract Currently, clinically used drug abuse medications exist for treatment of addiction to opiates, alcohol, and nicotine, but not psychostimulants, such as methamphetamine (METH). Compounds that co-activate both nociceptin opioid peptide (NOP) and mu receptors have potential for treatment of drug abuse. In particular, buprenorphine, a partial mu agonist/kappa antagonist, which also acts as a ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Reduction of Soft Tissue Injuries and Down Days with Female-Specific Collagen Intervention

    SBC: AMPHP INC            Topic: X22DOTCSO1

      Momentous seeks to deliver a joint health intervention designed specifically for female military servicemembers. It maximizes the benefit of collagen and vitamin C for injury reduction with novel additionals to limit increased injury risk due to the physiological impacsex-specificcific hormones. This effort will adapt the composition of Momentous Collagen Shot, a leading collagen product, to me ...

    STTR Phase I 2023 Department of DefenseAir Force
  5. Development and Pre-Clinical Testing of Antimicrobial PEKK/Silicon Nitride Trauma Plates with Carbon Fiber Reinforcement

    SBC: SINTX TECHNOLOGIES, INC.            Topic: NIAMS

    PROJECT SUMMARY—More than 2 million Americans are hospitalized each year with bone fractures, and many more undergo outpatient procedures for fracture reduction and fixation. Some injuries can be treated with closed reduction and splinting or casting to immobilize the bone during healing. However, at some sites, more than half of fractures require open reduction and internal fixation. Despite ad ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  6. Application of Novel Composite Techniques in the Building of a VTOL Aircraft

    SBC: ELECTRAFLY LLC            Topic: AFX20DTCSO1

    Composites manufacturing using autoclave cured pre-preg materials is expensive, often size limited, labor intensive, and has slow cycle times limiting production. The AFRL reported the need for improved composite research and demonstrations related to the emerging Advanced Air Mobility market. This project will use novel, out of autoclave composite manufacturing methods including composites based ...

    STTR Phase II 2022 Department of DefenseAir Force
  7. Multi-Domain Scheduling, Coordination, Deconfliction, and Contingency Handling for Crowded Air Space

    SBC: COGNITECH CORPORATION            Topic: AFX20DTCSO1

    The coordination of manned and unmanned aircraft, artillery, firing lanes, and ground forces can be enhanced by a lane-based approach to asset trajectory planning. In the proposed Phase II STTR effort, we plan to develop an approach, software prototype, simulation, and test and evaluation framework for the coordination of the trajectories of a large number of airborne coalition assets and dynamic ...

    STTR Phase II 2022 Department of DefenseAir Force
  8. Lightweight, Fuel Flexible Solid Oxide Fuel Cells for eVTOL Power System (SOFC)

    SBC: OXEON ENERGY LLC            Topic: AFX20DTCSO1

    Electric vertical take-off and landing (eVTOL) aircrafts are the emerging technology that is expected to revolutionize transportation industry. Agility Prime, a program launched by the Air Force is seeking to accelerate the commercial market for advanced air mobility vehicles. While Li-ion battery is the leading candidate to power these aircrafts, the drawbacks of the battery technology warrant re ...

    STTR Phase II 2022 Department of DefenseAir Force
  9. A web-based platform to support team-based genome diagnostics

    SBC: FRAMESHIFT LABS INC            Topic: 172

    Summary/Abstract Genomic sequencing is rapidly becoming a standard tool in diagnosing complex diagnostic cases, especially in critically ill newborns, and patients suffering from rare diseases. Current programs focused on addressing these cases utilise a team-based approach to identify, interpret and evaluate a patient’s genetic variants. These diverse teams include bioinformaticians, medical ge ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  10. Innovative Priming Solution for Enhanced Tactical Performance

    SBC: AMPHP INC            Topic: AF21BTCSO1

    Amp Human proposes developing a military-specific adaptation of its Prime Rinse commercial product (itself in mid-stage R&D) that signals the brain ease its regulation of physical performance. As a venture-backed human performance company, Amp Human’s exp

    STTR Phase I 2022 Department of DefenseAir Force
US Flag An Official Website of the United States Government